ART-501, formerly known as ARD-501 or TLX-032 for Tulex, is a proprietary oral liquid extended-release formulation of an existing, well-tolerated opioid receptor modulating drug developed through a ...

ECDC advocates for execution of respiratory syncytial virus (RSV) immunization programs including maternal vaccines to protect infants from severe hospitalization.

Scientific interest in cannabis has accelerated at an unprecedented pace, with 2025 producing more peer-reviewed research ...